# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
New Data Presented at Heart Rhythm Society Conference Demonstrates Continued Progress with Company's AI ProgramData Show Th...
Benchmark analyst Bill Sutherland reiterates HeartBeam (NASDAQ:BEAT) with a Speculative Buy and maintains $8 price target.
HeartBeam (NASDAQ:BEAT) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.15) b...
New Data Presented at the European Heart Rhythm Association Conference Marks First Scientific Presentation on HeartBeam AI, the...
Benchmark analyst Bill Sutherland reiterates HeartBeam (NASDAQ:BEAT) with a Speculative Buy and maintains $8 price target.
Shares of FedEx Corporation (NYSE: FDX) rose sharply in today’s pre-market trading after the company reported better-than-expe...
HeartBeam (NASDAQ:BEAT) reported quarterly losses of $(0.13) per share which met the analyst consensus estimate.